- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
-
-
-
Ŗ
-
-
-

  1. ?
  1. 3 (33,33%)
    3 (33,33%)
    2 (22,22%)
    (, , )
    1 (11,11%)
    0 (0,00%)
    0 (0,00%)

, , . -, - . , . , V9p22.3, – 2q21, – 25, D – 19ql3.2, – 1112, F – 1613.3, G – 13ql3. – – . – ( ) , -, : , , , , . ( ) , . ( , , ) . . 3 3 75% , . 3 . () (, , ) ( - ). , , , . () : , , , , . ( ), , - . – , , ( , ), . , , .

20% : , . () , . (, , , , - - , , .), 2/3 20 . – .

( ) , , , , , , , . , ( ) . . . .

, . ().

: (, , ), , , ; – , . . , , , .

© 2009 Pharm-rating.ru